A BIOTECH outfit is floating on the American NASDAQ stock exchange, which could earn a fair few bob for the Irish taxpayer. One of the company’s execs turns out to be a rather interesting chap. ALX Oncology is a Dublin and California-headquartered biotechnology company focused on developing cancer therapies. It has just filed for a… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!